(Q37287456)

English

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?

scientific article published on 30 June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? (English)

1 reference

Europe PubMed Central

19 August 2017

1 reference

based on heuristic

inferred from title

neoadjuvant chemotherapy

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

8

object named as

I Vergote

1 reference

Europe PubMed Central

19 August 2017

author name string

I Vandenput

1

1 reference

Europe PubMed Central

19 August 2017

B Van Calster

2

1 reference

Europe PubMed Central

19 August 2017

A Capoen

3

1 reference

Europe PubMed Central

19 August 2017

K Leunen

4

1 reference

Europe PubMed Central

19 August 2017

P Berteloot

5

1 reference

Europe PubMed Central

19 August 2017

P Neven

6

1 reference

Europe PubMed Central

19 August 2017

Ph Moerman

7

1 reference

Europe PubMed Central

19 August 2017

F Amant

9

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

30 June 2009

1 reference

Europe PubMed Central

19 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

19 August 2017

101

1 reference

Europe PubMed Central

19 August 2017

2

1 reference

Europe PubMed Central

19 August 2017

244-249

1 reference

Europe PubMed Central

19 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605157

0 references

Role of cytoreduction in stage III and IV uterine papillary serous carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

6 September 2017

Relaxing the rule of ten events per variable in logistic and Cox regression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

6 September 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

6 September 2017

Surgical stage IV endometrial carcinoma: a study of 47 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

28 September 2017

Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

26 June 2018

The role of surgical cytoreduction in Stage IV endometrial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

26 June 2018

Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

3 September 2018

Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

3 September 2018

Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

3 September 2018

FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

3 September 2018

Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

3 September 2018

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720217

3 September 2018

Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy in uterine papillary serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete clinical responses to neoadjuvant chemotherapy for uterine serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy in stage X ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605157

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37287456&oldid=1530314609"